why choose us

First received: November 06, 2023

Clinical Trial: A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hepatic Impairment

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, Non-randomized, Parallel-Group Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Single Oral Dose of 200 mg Elacestrant in Subjects With Normal Hepatic Functi

Brief Summary: This is a Phase 1, multi-center, open-label, non-randomized, parallel group study to evaluate the effect of severe hepatic impairment on the PK, safety and tolerability of a single oral dose of Elacestrant.

Read more